Who
Arlene Morris
Director
Company insider
Files Form 4 as: Director, Cogent Biosciences; Director, Palatin Technologies; Director, Viridian Therapeutics; Director, Edgewise Therapeutics; Director, Viveve Medical; Director, Dimension Therapeutics; Director, Biodel; Director, MediciNova.
In numbers
- Trades disclosed
- 313
- Buys
- 2
- Sells
- 22
- Bought
- $29K
- Sold
- $19.7M
- Companies
- 9
- Companies where not an officer
- 8
- First trade
- 11 May 2006
- Last trade
- 27 Aug 2026
- Last filed
- 31 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 27 Aug 2026filed 31 Aug 2026 | COGT Cogent BiosciencesBiotechnology | SEC FORM 4 Code M | $236K41,927 at $5.64 | filing |
| 27 Aug 2026filed 31 Aug 2026 | COGT Cogent BiosciencesBiotechnology | SEC FORM 4 Code M | $9,0293,583 at $2.52 | filing |
| 27 Aug 2026filed 31 Aug 2026 | COGT Cogent BiosciencesBiotechnology | SEC FORM 4 Sold | $1.6M42,349 at $37.09 | filing |
| 27 Aug 2026filed 31 Aug 2026 | COGT Cogent Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —41,927 at $0.00 | filing |
| 27 Aug 2026filed 31 Aug 2026 | COGT Cogent Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —3,583 at $0.00 | filing |
| 27 Aug 2026filed 31 Aug 2026 | COGT Cogent BiosciencesBiotechnology | SEC FORM 4 Sold | $119K3,161 at $37.54 | filing |
| 27 Aug 2026filed 31 Aug 2026 | COGT Cogent Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —41,927 at $0.00 | filing |
| 27 Aug 2026filed 31 Aug 2026 | COGT Cogent Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —3,583 at $0.00 | filing |
| 27 Aug 2026filed 31 Aug 2026 | COGT Cogent BiosciencesBiotechnology | SEC FORM 4 Code M | $236K41,927 at $5.64 | filing |
| 27 Aug 2026filed 31 Aug 2026 | COGT Cogent BiosciencesBiotechnology | SEC FORM 4 Code M | $9,0293,583 at $2.52 | filing |
| 27 Aug 2026filed 31 Aug 2026 | COGT Cogent BiosciencesBiotechnology | SEC FORM 4 Sold | $1.6M42,349 at $37.09 | filing |
| 27 Aug 2026filed 31 Aug 2026 | COGT Cogent BiosciencesBiotechnology | SEC FORM 4 Sold | $119K3,161 at $37.54 | filing |
| 3 Aug 2026filed 5 Aug 2026 | PTN Palatin Technologiesoption or derivative · Biotechnology | SEC FORM 4 Code Z | —2,400 at $0.00 | filing |
| 3 Aug 2026filed 5 Aug 2026 | PTN Palatin Technologiesoption or derivative · Biotechnology | SEC FORM 4 Code Z | —2,400 at $0.00 | filing |
| 1 Jul 2026filed 2 Jul 2026 | VRDN Viridian Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —32,341 at $0.00 | filing |
| 1 Jul 2026filed 2 Jul 2026 | VRDN Viridian Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —32,341 at $0.00 | filing |
| 9 Jun 2026filed 11 Jun 2026 | COGT Cogent Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —17,901 at $0.00 | filing |
| 9 Jun 2026filed 11 Jun 2026 | COGT Cogent Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —17,901 at $0.00 | filing |
| 5 Jun 2026filed 17 Jun 2026 | EWTX Edgewise Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —16,377 at $0.00 | filing |
| 5 Jun 2026filed 17 Jun 2026 | EWTX Edgewise Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —16,377 at $0.00 | filing |
News
Cogent Biosciences (COGT) Nears Three FDA Decisions. What Is Its Pipeline Worth?COGT · insidermonkey.com · 20 Oct 2026
0 headlines in the last 90 days name Arlene Morris; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.